List of Tables
Table 1: Molecular Subtypes of Breast Cancer 14
Table 2: Definitions of HER2 Status by IHC Staining 15
Table 3: Breast Cancer Therapeutics, Global, Tumor, Nodes and Metastasis Staging, 2010–2013 20
Table 4: Breast Cancer Therapeutics Market, Global, Licensing Deals Valued $100m and Above, 2007–2017 141
Table 5: Breast Cancer Therapeutics Market, Global, Co-development Deals Value, 2007–2017 147
Table 6: Breast Cancer Therapeutics Market, Global, All Pipeline Products, Discovery, 2018 148
Table 7: Breast Cancer Therapeutics Market, Global, All Pipeline Products, Preclinical, 2018 154
Table 8: Breast Cancer Therapeutics Market, Global, All Pipeline Products, IND/CTA- filed, 2018 176
Table 9: Breast Cancer Therapeutics Market, Global, All Pipeline Products, Phase I, 2018 177
Table 10: Breast Cancer Therapeutics Market, Global, All Pipeline Products, Phase II, 2018 184
Table 11: Breast Cancer Therapeutics Market, Global, All Pipeline Products, Phase III, 2018 190
Table 12: Breast Cancer Therapeutics Market, Global, All Pipeline Products, Pre-registration, 2018 191
Table 13: Breast Cancer Therapeutics Market, APAC, Market Forecast, 2017–2024 192
Table 14: Breast Cancer Therapeutics Market, India, Market Forecast, 2017–2024 192
Table 15: Breast Cancer Therapeutics Market, China, Market Forecast, 2017–2024 192
Table 16: Breast Cancer Therapeutics Market, Australia, Market Forecast, 2017–2024 193
Table 17: Breast Cancer Therapeutics Market, South Korea, Market Forecast, 2017–2024 193
Table 18: Breast Cancer Therapeutics Market, Japan, Market Forecast, 2017–2024 193